Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2009 Jul; 54(1):59-69.
View in:
PubMed
subject areas
Aged
Anemia
Cardiovascular Diseases
Cohort Studies
Darbepoetin alfa
Diabetes Mellitus, Type 2
Erythropoietin
Female
Glomerular Filtration Rate
Hematinics
Humans
Kidney Diseases
Male
Middle Aged
Proteinuria
Risk Factors
Treatment Outcome
authors with profiles
Ajaypal Singh